Statin intensity and risk for cardiovascular events after heart transplantation. [PDF]
Aims Statins improve survival and reduce rejection and cardiac allograft vasculopathy after heart transplantation (HT). The impact of different statin intensities on clinical outcomes has never been assessed.
Golbus JR +5 more
europepmc +5 more sources
Clinical impact of statin intensity according to age in patients with acute myocardial infarction. [PDF]
Background The available data are not sufficient to understand the clinical impact of statin intensity in elderly patients who undergo percutaneous coronary intervention (PCI) due to acute myocardial infarction (AMI). Methods Using the COREA-AMI registry,
Lee K +18 more
europepmc +4 more sources
Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study. [PDF]
Background Current guidelines recommend life-long use of statin for patients with type 2 diabetes (T2D), however, a number of patients discontinue statin therapy in clinical practice.
Kim JY, Choi J, Kim SG, Kim NH.
europepmc +3 more sources
Real-World Evaluation of the Impact of Statin Intensity on Adherence and Persistence to Therapy: A Scottish Population-Based Study [PDF]
To assess associations between statin intensity and adherence, persistence and discontinuation of statin therapy in Scotland.
Amanj Kurdi +2 more
exaly +3 more sources
Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study. [PDF]
Background Comparative studies regarding the long-term clinical outcomes of statin intensity between acute myocardial infarction (AMI) patients with prediabetes and those with type 2 diabetes mellitus (T2DM), after successful implantation of newer ...
Kim YH +11 more
europepmc +3 more sources
New onset diabetes mellitus and cardiovascular outcomes according to statin intensity in patients after drug-eluting stent implantation in Asian patients. [PDF]
We investigated the effect of statin intensity on the development of new onset diabetes mellitus (NODM) in Korean patients after percutaneous coronary intervention (PCI). A total of 1013 consecutive patients without diabetes mellitus were retrospectively
Chung J +6 more
europepmc +3 more sources
Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study. [PDF]
Aims Clinical trials have demonstrated that a reduction in low-density lipoprotein cholesterol (LDL-C) reduces cardiovascular (CV) events. This has, however, not yet been shown in a real-world setting. We aimed to investigate the association between LDL-
Schubert J +12 more
europepmc +2 more sources
Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE. [PDF]
Introduction The phase IIIb open-label ODYSSEY APPRISE study prospectively assessed the safety and efficacy of alirocumab (a proprotein convertase subtilisin/kexin type 9 [PCSK9] inhibitor) in a real-life setting in high cardiovascular risk patients with
Banach M +8 more
europepmc +2 more sources
Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy. [PDF]
Background: In the non-transplant population, hyperlipidaemia has shifted from targeting LDL goals to statin intensity-based treatment. It is unknown whether this strategy is also beneficial in cardiac transplantation.
Ellimuttil TM +6 more
europepmc +2 more sources
LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study. [PDF]
Background Clinical trials have demonstrated that either initiating or up-titrating a statin dose substantially reduce Low-Density Lipoprotein-Cholesterol (LDL-C) levels.
Fang HSA, Gao Q, Lee ML, Hsu W, Tan NC.
europepmc +2 more sources

